Availability of drugs is being monitored by implementing a three-pronged strategy of supply chain management, demand side management, and affordability.
State governments and UTs have been asked to monitor proper distribution within the state/UT covering government and private hospitals
The facility is expected to be completed in 2024
The Department of Pharmaceuticals launched the PLI scheme for promoting domestic manufacturing of bulk drugs, with a financial outlay of Rs. 6,940 crore across 53 APIs over 6 years
Essential medicines were made available to more than 150 countries around the world during the pandemic
India produces 60% of the world’s vaccine
The vaccine was 85 percent effective in preventing severe disease across all regions.
The Indian pharma industry has grown at a compounded growth rate of ~11% in the domestic market and ~16% in exports over the last two decades
Pharma industry is ready to embrace technology platforms with a keen focus on automation in manufacturing and digital health investment.
Building upon the momentum gained by pharma sector during the pandemic, Indian Pharmaceutical Alliance is leaving no stone unturned to create a faster road to recovery.
Subscribe To Our Newsletter & Stay Updated
